News
These are tough times for American hackers, and rife with uncertainty. Trade wars are on, off, on again– who can keep track?
Results of Ideate-Lung01 trial at WCLC back up MSD and Daiichi Sankyo's decision to move anti-B7-H3 ADC I-Dxd into phase 3 for small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback